HANSA BIOPHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.32 SEK | +0.44% |
|
-6.76% | +4.27% |
| Apr. 18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
| Apr. 18 | Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Hansa Biopharma AB
Price target over the last 5 years
History of analyst recommendation changes
3d5f77f74dc51d9648edef229605b630.v1LhXpJQSIvFuRCu4sVs6c1XAJ5PNCYipcpkYx5dr2Q.iyWCL6IXAfn20iSep6YK0Z4ka9UddWhjzokVUXoS5iH-JtEZ8T1x8bzuQQ~8cca7f1affa7b331308ac6c62c594313
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
27.32
SEK
Average target price
105
SEK
Spread / Average Target
+284.33%
High Price Target
175
SEK
Spread / Highest target
+540.56%
Low Price Target
57
SEK
Spread / Lowest Target
+108.64%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- HNSA Stock
- Consensus Hansa Biopharma AB
